Ningbo David Medical Device Co., Ltd. (SHE:300314)
11.53
-0.07 (-0.60%)
Sep 4, 2026, 3:04 PM CST
SHE:300314 Revenue
Ningbo David Medical Device had revenue of 139.11M CNY in the quarter ending June 30, 2026, with 6.93% growth. This brings the company's revenue in the last twelve months to 584.68M, up 14.09% year-over-year. In the year 2025, Ningbo David Medical Device had annual revenue of 584.03M with 10.82% growth.
Revenue (ttm)
584.68M
Revenue Growth
+14.09%
P/S Ratio
5.71
Revenue / Employee
635.52K
Employees
920
Market Cap
3.34B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 584.03M | 57.00M | 10.82% |
| Dec 31, 2024 | 527.03M | -91.27M | -14.76% |
| Dec 31, 2023 | 618.30M | 112.26M | 22.18% |
| Jan 1, 2023 | 506.04M | 31.90M | 6.73% |
| Jan 1, 2022 | 474.13M | 14.60M | 3.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.69B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Chison Medical Technologies | 441.10M |
| Medprin Regenerative Medical Technologies | 400.85M |
| Tellgen | 392.11M |
| Shanghai General Healthy Information and Technology | 371.61M |
| CareRay Digital Medical Technology | 319.79M |
| Beijing Leadman Biochemistry | 317.79M |